Medicamentos como Ozempic y Wegovy, que contienen semaglutida (un agonista de GLP-1), han ganado popularidad gracias a su capacidad para mejorar el control de la glucosa y facilitar una significativa prdida de peso
Semaglutide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, and slows gastric emptying
In endothelial cell models, BPC-157 significantly enhanced ERK1/2 phosphorylation in a dose-dependent manner, leading to increased cellular proliferation, migration, and vascular tube formation
Focus on magnesium-rich foods (spinach, pumpkin seeds, almonds), potassium sources (sweet potato, banana, coconut water), and adequate salt intake
This deal is currently only available if you purchase the meds directly from Eli Lilly